Literature DB >> 17414848

Sclerosing cholangitis.

James Rl Maggs1, Roger W Chapman.   

Abstract

PURPOSE OF REVIEW: Primary sclerosing cholangitis is a chronic cholestatic liver disease characterized by strictures of the biliary tree complicated by cirrhosis and cholangiocarcinoma. It is immune mediated, although the precise aetiology remains unknown. RECENT
FINDINGS: Research into etiopathogenesis and epidemiology, diagnosis of cholangiocarcinoma, associations with inflammatory bowel disease and autoimmune pancreatitis, and medical therapy are discussed.
SUMMARY: Multiple gene polymorphisms associated with primary sclerosing cholangitis have been investigated. Common inflammatory bowel disease-associated polymorphisms do not confer any susceptibility to primary sclerosing cholangitis; the role of intercellular adhesion molecule-1 gene polymorphisms and CCR5 mutations remain unclear. Elevated IgG4 has been demonstrated in a subgroup of primary sclerosing cholangitis patients, which may indicate an overlap with autoimmune pancreatitis and possible responsiveness to steroids. Biliary brush cytology may assist in diagnosis of cholangiocarcinoma, although further clinical indicators are required. Animal studies suggest the superiority of 24-norursodeoxycholic acid over ursodeoxycholic acid in reducing histological disease progress; translational studies in humans are now required.

Entities:  

Mesh:

Year:  2007        PMID: 17414848     DOI: 10.1097/MOG.0b013e32805867e6

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  3 in total

1.  Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

Authors:  A M Arenas-Gamboa; J J Bearss; G B Hubbard; B F Porter; M A Owston; E J Dick
Journal:  Vet Pathol       Date:  2011-09-20       Impact factor: 2.221

2.  Secondary sclerosing cholangitis after intensive care unit treatment: clues to the histopathological differential diagnosis.

Authors:  Irene Esposito; Andrea Kubisova; Adolf Stiehl; Hasan Kulaksiz; Peter Schirmacher
Journal:  Virchows Arch       Date:  2008-09-04       Impact factor: 4.064

3.  The best approach for diagnosing primary sclerosing cholangitis.

Authors:  Wellington Andraus; Luciana Haddad; Lucas Souto Nacif; Felipe D Silva; Roberto Blasbalg; Luiz Augusto Carneiro D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.